# Fake Peptides, Eli Lilly's Breakthrough & The S&P Split | GCP 1007

Page: https://stenobird.com/podcast/group-chat-1064096/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007
Text version: https://stenobird.com/podcast/group-chat-1064096/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007.md
Podcast: [Group Chat](https://stenobird.com/podcast/group-chat-1064096)
Published: 2026-05-26T07:39:00+00:00
Episode link: https://groupchat.libsyn.com/fake-peptides-eli-lillys-breakthrough-the-sp-split-gcp-1007
Audio file: https://traffic.libsyn.com/secure/groupchat/GCP_1007_PODCAST_mixdown.mp3?dest-id=2184830
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/group-chat-1064096/episodes/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007
Duration seconds: 4442

## Resource

Group Chat News is back with the hottest stories of the week. We get into fake peptides showing up in pools and locker rooms, Eli Lilly's gene therapy IV that drops cholesterol 65% for 18 months, and the wild gap between an S&P at all-time highs and consumer sentiment at all-time lows. We dig into the AI optimist vs. pessimist split, Andrew Sorkin's 1929 doomer pitch on 60 Minutes, and why the next Carnegies need to start building parks and libraries to win back public sentiment,the American fitness test, and much more

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/group-chat-1064096/episodes/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/group-chat-1064096/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.